Boston ups women’s health output with BHN deal
This article was originally published in Clinica
Executive Summary
Boston Scientific has signed a four-year exclusive marketing deal with Bladder Health Network (BHN) for the latter’s female urodynamic testing solutions. The collaboration will see Boston’s urology and women’s health division sell BHN’s technology in the US. BHN (Jackson, Mississippi) offers urodynamic testing software, staffing, results analysis tools and other equipment. According to Natick, Massachusetts-based Boston, urinary incontinence affects one in four women in the US. Boston’s women’s health portfolio already includes mid-urethral sling systems designed to treat stress urinary incontinence (SUI), the Coaptite injectable implant for soft tissue augmentation in the treatment of SUI due to intrinsic sphincter deficiency, the Capio PFR kit for the treatment of pelvic floor reconstruction, the Xenform tissue repair matrix for reinforcing soft tissues and the Polyform synthetic mesh for pelvic organ prolapse.